PHYHD1-mediated translational control regulates renal cell carcinoma progression.

Loss of PHYHD1 promotes renal cell carcinoma progression by enhancing CERT1 translation and disrupting translational homeostasis.

• Why it matters: Understanding the mechanisms driving RCC progression is crucial for developing targeted therapies, especially since PHYHD1 loss correlates with poor prognosis and tumor advancement.
• What they did: The study used integrative deep learning analysis of pan-cancer datasets and experimental models, including RCC cell lines and patient-derived xenografts, to investigate PHYHD1's role and its interaction with translation machinery.
• The result: Restoring PHYHD1 suppresses tumor growth independently of its dioxygenase activity, and targeting CERT1 impairs proliferation in PHYHD1-deficient cells, suggesting CERT1 as a potential therapeutic target.